Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer - Shiotani, A; Murao, T; Kimura, Y; Matsumoto, H; Kamada, T; Kusunoki, H; Inoue, K; Uedo, N; Iishi, H; Haruma, K (British journal of cancer, 2013)
Keywords: 631/337/384/331; 692/53/2421; 692/699/67/1504/1829; Aged; Biological and medical sciences; Biomarkers; Biomarkers, Tumor - blood; Biomarkers, Tumor - genetics; Biomedical and Life Sciences; Biomedicine; Cancer Research; Case-Control Studies; Clinical Study; Drug Resistance; Endoscopy; Enzyme-linked immunosorbent assay; Epidemiology; Female; Gastric cancer; Gastric Mucosa - microbiology; Gastric Mucosa - pathology; Gastroenterology. Liver. Pancreas. Abdomen; Helicobacter; Helicobacter Infections - blood; Helicobacter Infections - diagnosis; Helicobacter Infections - microbiology; Helicobacter Infections - pathology; Helicobacter pylori - isolation & purification; Humans; Male; Medical sciences; Medical screening; MicroRNAs; MicroRNAs - blood; Molecular Medicine; Multiple tumors. Solid tumors. Tumors in childhood (general aspects); Oncology; Pepsinogen A - blood; Pepsinogen C - blood; Stomach Neoplasms - blood; Stomach Neoplasms - genetics; Stomach Neoplasms - microbiology; Stomach Neoplasms - pathology; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Tumors; Japan; miR-21; eradication; miR-106b; pepsinogen; High risk; RNA interference; Spirillaceae; Biological marker; Identification; H. pylori eradication; Eradication; Stomach cancer; Cancerology; Helicobacter pylori; Bacteria; Serum; Diagnosis; Gastric disease; Spirillales; Micro RNA; Malignant tumor; Pepsinogen; Gene silencing; Digestive diseases; Early; Detection; Cancer